While American investors enjoy a period of unprecedented growth in both commercial and residential real estate, some savvy industry leaders are starting to use their real estate dividends to make an impact in the field of pharmaceutical research and biotechnology. Across the country, more than 2,500 individual biotechnology companies are hard at work, looking to…